| Synthesis and characterization of surface-enhanced Raman-scattered gold nanoparticles S Kalmodia, J Harjwani, R Rajeswari, W Yang, CJ Barrow, ... International journal of nanomedicine, 4327-4338, 2013 | 34 | 2013 |
| Clinico-pathological association of delineated miRNAs in uveal melanoma with monosomy 3/disomy 3 chromosomal aberrations N Venkatesan, J Kanwar, PR Deepa, V Khetan, TM Crowley, ... PloS one 11 (1), e0146128, 2016 | 29 | 2016 |
| Therapeutic approaches targeting molecular signaling pathways common to diabetes, lung diseases and cancer R Raguraman, A Srivastava, A Munshi, R Ramesh Advanced drug delivery reviews 178, 113918, 2021 | 22 | 2021 |
| RNA binding proteins (RBPs) and their role in DNA damage and radiation response in cancer M Mehta, R Raguraman, R Ramesh, A Munshi Advanced drug delivery reviews 191, 114569, 2022 | 19 | 2022 |
| Evidence of tumour microenvironment and stromal cellular components in retinoblastoma R Raguraman, S Parameswaran, JR Kanwar, V Khetan, P Rishi, ... Ocular Oncology and Pathology 5 (2), 85-93, 2019 | 17 | 2019 |
| Tumor-targeted exosomes for delivery of anticancer drugs R Raguraman, D Bhavsar, D Kim, X Ren, V Sikavitsas, A Munshi, ... Cancer letters 558, 216093, 2023 | 16 | 2023 |
| Targeting HMGA2 in retinoblastoma cells in vitro using the aptamer strategy V Nalini, PR Deepa, R Raguraman, V Khetan, MA Reddy, ... Ocular oncology and pathology 2 (4), 262-269, 2016 | 15 | 2016 |
| Drug delivery approaches for HuR-targeted therapy for lung cancer R Raguraman, S Shanmugarama, M Mehta, JE Peterson, YD Zhao, ... Advanced drug delivery reviews 180, 114068, 2022 | 14 | 2022 |
| AKT1 transcriptomic landscape in breast cancer cells B George, B Gui, R Raguraman, AM Paul, H Nakshatri, MR Pillai, ... Cells 11 (15), 2290, 2022 | 8 | 2022 |
| Multiple G-quadruplex binding ligand induced transcriptomic map of cancer cell lines A Revikumar, V Kashyap, A Palollathil, A Aravind, R Raguraman, ... Journal of Cell Communication and Signaling 16, 129-135, 2022 | 5 | 2022 |
| Gene expression profiling of tumor stroma interactions in retinoblastoma R Raguraman, S Parameswaran, JR Kanwar, M Vasudevan, S Chitipothu, ... Experimental Eye Research 197, 108067, 2020 | 3 | 2020 |
| HuR-targeted therapy promotes the adaptive immune response in medulloblastoma through the cGAS-Sting pathway M Mehta, R Raguraman, A Munshi, R Ramesh Cancer Research 84 (6_Supplement), 5929-5929, 2024 | | 2024 |
| Deciphering the role of tumor microenvironment in the invasion and progression of retinoblastoma R Raguraman Deakin University, 2017 | | 2017 |
